Q32 Bio Inc (QTTB) Stock Analysis

Q32 Bio Inc (QTTB) is a publicly traded company in the HEALTHCARE sector. It trades at $12.64, carries a market capitalization of $187.37M, a price-to-earnings ratio of 3.98. This page summarizes the public market data, fundamentals, and frequently asked questions for QTTB, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $12.64
• Market Cap: $187.37M
• P/E Ratio: 3.98
• EPS: $2.78
• 52-Week High: $13.15
• 52-Week Low: $1.34

Market Sentiment

Q32 Bio Inc currently has a Bullish sentiment score of 0.33.

About Q32 Bio Inc

None

GNG Research Analysis

GNG Research scores Q32 Bio Inc (QTTB) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for QTTB.

Frequently Asked Questions

Does QTTB pay dividends?

Q32 Bio Inc (QTTB) does not currently pay a regular dividend.

What is QTTB's P/E ratio?

Q32 Bio Inc has a price-to-earnings (P/E) ratio of 3.98.

What is QTTB's market cap?

Q32 Bio Inc (QTTB) has a market capitalization of $187.37M with a current stock price of $12.64.